The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
about
Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot studyMassive Pulmonary Embolism in a Patient with Heparin Induced Thrombocytopenia: Successful Treatment with Dabigatran.Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach.Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia.Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Beyond heparin and warfarin: the new generation of anticoagulants.Heparin-induced thrombocytopenia: treatment options and special considerations.Heparin-induced thrombocytopenia and recent advances in its therapy.Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case seriesThe use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushesFondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Catastrophic complication following heparin therapy.The status of new anticoagulants.Effectiveness of Heparin during Long-Term Tocolysis.
P2860
Q24642002-F317F689-DB3A-47DD-9805-7B810757AEE5Q33166993-0A3FE427-3DA1-4857-8E77-F57FC6E9DC47Q33368911-352858E9-6CBB-41E4-8ABB-1C1B105C6788Q33369244-B4B33E97-5711-48F6-A441-FAB600FF128EQ33370149-A7EB7119-17DD-4CA9-8C44-13A5BF8EDF27Q33371628-82820DA7-C656-4357-A658-A2C4CAB1A978Q33372751-C8D8FD63-A225-46FA-877B-7B5C1FCFE696Q33373392-275B7CDC-4838-442B-8457-220BAD326BE7Q33373700-51C7D209-C58C-4F84-AEEE-B0D96166FF45Q33374258-BDBB7445-8F8C-478A-AD6E-5934085D151DQ33374658-6CDA3986-1F38-4859-9B7E-A11935E82470Q33377436-3005B905-0041-43E0-877E-C05CF8DA181BQ33380179-1E40E30C-FFC3-450D-8D27-BEEAD0CCE0FBQ33381352-1540CF2C-AD60-4450-ACB4-420853ABDECFQ33386621-5C504E9C-A14E-421A-A8AD-0CBBBB1F9B72Q33401236-B126458C-89E7-4369-9B3E-D1B19BB92425Q33415667-F59373DA-1ECA-4023-8A33-09912B9BEE13Q36520745-0D5254BD-B43A-4130-ADC5-A2B70285E5D3Q36755035-7C60EF0A-6E73-4667-884C-AAA0020BF488
P2860
The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The management of patients wit ...... require anticoagulant therapy.
@ast
The management of patients wit ...... require anticoagulant therapy.
@en
type
label
The management of patients wit ...... require anticoagulant therapy.
@ast
The management of patients wit ...... require anticoagulant therapy.
@en
prefLabel
The management of patients wit ...... require anticoagulant therapy.
@ast
The management of patients wit ...... require anticoagulant therapy.
@en
P1433
P1476
The management of patients wit ...... require anticoagulant therapy.
@en
P2093
Kathryn Hassell
P356
10.1378/CHEST.127.2_SUPPL.1S
P407
P433
P577
2005-02-01T00:00:00Z